Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Monte Rosa Therapeutics Inc (NQ: GLUE ) 8.840 -0.060 (-0.67%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Monte Rosa Therapeutics Inc < Previous 1 2 3 4 Next > Monte Rosa Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating MRT-2359, a GSPT1-directed Molecular Glue Degrader, for Treatment of MYC-driven Tumors November 01, 2022 From Monte Rosa Therapeutics, Inc. Via GlobeNewswire 5 Value Stocks In The Healthcare Sector October 17, 2022 What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... Via Benzinga Albertsons Companies, Domino's Pizza And Other Big Gainers From Thursday October 14, 2022 U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business August 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 October 13, 2022 Upgrades Via Benzinga Monte Rosa Shares Rise As FDA Announced Clearance To MYC-Driven Cancer Study September 06, 2022 The U.S. Food and Drug Administration (FDA) has announced clearance to Monte Rosa Therapeutics’ (NASDAQ: GLUE) investigational new drug application (IND) for its drug candidate MRT-2359 in patients... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022 August 15, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022 April 28, 2022 Via Benzinga This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday July 29, 2022 Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,... Via Benzinga 63 Biggest Movers From Yesterday June 17, 2022 Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session March 07, 2022 Gainers TherapeuticsMD (NASDAQ:TXMD) stock moved upwards by 38.1% to $0.29 during Monday's regular session. As of 12:30 EST, TherapeuticsMD's stock is trading at a... Via Benzinga 53 Biggest Movers From Yesterday March 30, 2022 Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022 February 10, 2022 Upgrades According to Gordon Haskett, the prior rating for Williams-Sonoma Inc (NYSE:WSM) was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter,... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday January 25, 2022 On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap... Via Benzinga 50 Biggest Movers From Yesterday January 06, 2022 Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session December 28, 2021 Gainers BridgeBio Pharma (NASDAQ:BBIO) shares increased by 17.7% to $13.39 during Tuesday's regular session. Trading volume for this security as of 12:32 EST is 25.2... Via Benzinga 56 Biggest Movers From Friday November 29, 2021 Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on... Via Benzinga 66 Biggest Movers From Friday November 01, 2021 Gainers Bakkt Holdings, Inc. (NASDAQ: BKKT) shares surged 66.1% to close at $42.52 on Friday on continued volatility after the company recently announced partnerships with... Via Benzinga Biotech Company Pasithea Offers Two-Pronged Approach in Psychiatric Treatment October 05, 2021 Photo by Dimitri Karastelev on Unsplash Pasithea Therapeutics (NASDAQ: KTTA), a Florida-based biotechnology company, strives to discover new treatments for mental and neurological... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 October 14, 2021 Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX: Via Benzinga The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO August 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... Via Benzinga Exposures COVID-19 54 Biggest Movers From Yesterday September 09, 2021 Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday. Helbiz, Inc. (NASDAQ: HLBZ) gained 84% to... Via Benzinga The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug August 25, 2021 ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod September 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself September 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... Via Benzinga The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration August 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Topics Intellectual Property Exposures Intellectual Property The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal August 24, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... Via Benzinga Exposures Product Safety Stocks That Hit 52-Week Highs On Monday August 23, 2021 Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG... Via Benzinga The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data August 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma August 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
